Management of Excessive Sleepiness: Case Examples CME/CE

Author Information and Disclosures

Release Date: January 31, 2008; Valid for credit through January 31, 2009

Credits Available
Physicians - maximum of 1.0 AMA PRA Category 1 Credit(s)™ for physicians;
Nurses - 1.0 nursing contact hours (None of these credits is in the area of pharmacology)

To participate in this internet activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details.

Legal Disclaimer

The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.

Copyright © 2008 Medscape.
Cephalon
Learning Objectives

Upon completion of this activity, participants will be able to:

  1. Describe the patient history, including the negative consequences of excessive sleepiness (ES) experienced by the patient
  2. Explore the patient assessment and diagnostic strategies
  3. Evaluate a patient's description of symptoms and make a differential diagnosis
  4. Examine nonpharmacologic and pharmacologic approaches to address the treatment of sleep disorders and ES
  5. Discuss patient monitoring and follow-up
Authors and Disclosures

Jed Black, MD
Disclosure: Jed Black, MD, has disclosed that he has received grants for clinical research and served as an advisor or consultant to Boehringer Ingelheim, GlaxoSmithKline, Cephalon, Jazz Pharmaceuticals, and Takeda.


David Danar
Disclosure: David Danar has disclosed that he owns a small quantity of Pfizer Inc stock.
 
Medscape
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Medscape, LLC designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Contact This Provider

 
This Activity is sponsored by Medscape Continuing Education Provider Unit.

Medscape is an approved provider of continuing nursing education by the New York State Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.

Awarded 1.0 contact hour(s) of continuing nursing education for RNs and APNs; none of these credits is in the area of pharmacology.

Provider Number: 6FDKKC-PRV-05

Contact This Provider

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.